{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:54:30Z","timestamp":1760622870187,"version":"3.41.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/igc.0b013e3182647265","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T05:59:18Z","timestamp":1346219958000},"page":"1420-1426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Feasibility and Acute Toxicity of Concurrent Chemoradiotherapy (CCRT) With High-Dose Rate Intracavitary Brachytherapy (HDR-ICBT) and 40-mg\/m2 Weekly Cisplatin for Japanese Patients With Cervical Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Takafumi","family":"Toita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsutaro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Umayahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182647265_bb0005","article-title":"Clinical Practice Guidelines in Oncology\u2014Cervical Cancer v.1","author":"NCCN","year":"2011","journal-title":"NCCN Clinical Practice Guidelines in Oncology."},{"key":"10.1097\/IGC.0b013e3182647265_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10147-010-0061-x","article-title":"Japan Society of Gynecologic Oncology. Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition","volume":"15","author":"Nagase","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182647265_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e3182647265_bb0020","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1200\/JCO.2002.20.4.966","article-title":"Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix","volume":"20","author":"Pearcey","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00066-002-0956-1","article-title":"Chemoradiation in cervical cancer with cisplatin and highYdose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study","volume":"178","author":"Strauss","year":"2002","journal-title":"Strahlenther Onkol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0030","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijrobp.2004.04.042","article-title":"Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity","volume":"60","author":"Serkies","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0035","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ijrobp.2006.07.004","article-title":"Concurrent weekly cisplatin plus external beam radiotherapy and high\u2013dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications","volume":"66","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijrobp.2008.06.1920","article-title":"Five years\u2019 experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution","volume":"74","author":"Parker","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0045","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/IGC.0b013e3181e6f321","article-title":"Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and highYdose rate brachytherapy in locally advanced carcinoma of the cervix","volume":"20","author":"Forrest","year":"2010","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e3182647265_bb0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/IGC.0b013e3181d4a0d1","article-title":"Concurrent chemoradiotherapy incorporating highYdose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors","volume":"20","author":"Teh","year":"2010","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e3182647265_bb0055","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1200\/JCO.2004.00.0497","article-title":"Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study","volume":"23","author":"Lanciano","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ygyno.2007.10.011","article-title":"Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g\/dL with erythropoietin vs above 10.0 g\/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer","volume":"108","author":"Thomas","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0065","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02493277","article-title":"Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin","volume":"24","author":"Ikushima","year":"2006","journal-title":"Radiat Med."},{"key":"10.1097\/IGC.0b013e3182647265_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10147-006-0567-4","article-title":"Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy: a phase I study in Japanese patients with cancer of the uterine cervix","volume":"11","author":"Watanabe","year":"2006","journal-title":"Int J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image\u2013based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijrobp.2007.10.045","article-title":"Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan","volume":"70","author":"Toita","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijrobp.2010.10.030","article-title":"International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)","volume":"82","author":"Viswanathan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0095","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0360-3016(03)00288-8","article-title":"Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule","volume":"56","author":"Toita","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cncr.20734","article-title":"Long-term results of highYdose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix","volume":"103","author":"Nakano","year":"2005","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e3182647265_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2012.04.036","article-title":"Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedules","volume":"126","author":"Toita","year":"2012","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1259\/0007-1285-11-132-809","article-title":"A dosage system for use in the treatment of cancer of the uterine cervix","volume":"11","author":"Tod","year":"1938","journal-title":"Br J Radiol."},{"year":"1985","series-title":"Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology. ICRU report 38","author":"ICRU","key":"10.1097\/IGC.0b013e3182647265_bb0115"},{"key":"10.1097\/IGC.0b013e3182647265_bb0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10147-011-0196-4","article-title":"Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer","volume":"16","author":"Toita","year":"2011","journal-title":"Int J Clin Oncol."},{"key":"10.1097\/IGC.0b013e3182647265_bb0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.06.011","article-title":"Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia","volume":"77","author":"Kato","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1097\/IGC.0b013e3182647265_bb0130","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/ijgc-00009577-200607000-00020","article-title":"A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy","volume":"16","author":"Nyongesa","year":"2006","journal-title":"Int J Gynecol Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2402560X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2402560X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e3182647265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:17:44Z","timestamp":1753222664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2402560X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1048891X2402560X"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182647265","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and Acute Toxicity of Concurrent Chemoradiotherapy (CCRT) With High-Dose Rate Intracavitary Brachytherapy (HDR-ICBT) and 40-mg\/m2 Weekly Cisplatin for Japanese Patients With Cervical Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182647265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}